At the Envision Summit 2025 in San Juan, Puerto Rico, Mike Farkas, MD, discussed gene therapy research for retinal ...

The Franklin County Board of Commissioners has passed a resolution urging the Benton Franklin Health District (BFHD) to cease providing, funding, and promoting gene-therapy vaccines until ...

An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its ...

Sickle cell disease is a severe, inherited blood disorder that primarily affects people of African, Mediterranean, Middle ...

The move comes after Commission Chairman Clint Didier invited a group of vaccine skeptics to speak at two recent meetings. It’s the same group behind recent pushes in Idaho to stop offering the ...

bluebird stockholders to receive $3.00 per share in cash and a contingent value right of $6.84 per share in cash payable upon achievement of a net sales ...

Workplace Bullying's Sleep Impact Spreads to Partners, reveals studyWorkplace bullying affects not only the employee’s sleep ...

NKGen takes a meaningful step towards potential treatment for frontotemporal dementia (“FTD”) patients with limited treatment options.

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...

Jaime Bortz, 39, is losing her memory to dementia. Her mom, now a full-time carer, is foreshadowing the burden many families ...

In a sense, every investor is a growth investor. Even those who are primarily seeking income enjoy when the stocks they buy ...